Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C

MONDO:0014212

A molybdenum cofactor deficiency that has material basis in homozygous mutation in the GPHN gene on chromosome 14q23.

Also known as: MOCOD type C, MOCODC, combined deficiency of sulfite oxidase, xanthine dehydrogenase and aldehyde oxidase type C, molybdenum cofactor deficiency C, molybdenum cofactor deficiency, complementation group type C, molybdenum cofactor deficiency type C, molybdenum cofactor deficiency, complementation group C

38 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Broader categories

Disease (618) Metabolic disease (215) Hereditary disease (172) Eye disorder (97) Inborn errors of metabolism (42) Human disease (14) Lens disorder (10) Developmental defect during embryogenesis (7) Disorder of orbital region (3) Disease of genetic or genomic mechanism (2)

Trials to join now! 22 Not yet recruiting 3 Not yet finished but already full! 4 Completed 8 Terminated 1

VR headsets tested as a possible treatment for blindness

Disease control Terminated

This study tested whether using a virtual reality headset for one-hour sessions could help regenerate damaged optic nerves and improve vision in people with glaucoma or other retinal diseases. The idea came from promising results in rodents. However, the trial was terminated earl…

Phase: NA • Sponsor: Stanford University • Aim: Disease control

Last updated Jun 27, 2026 08:03 UTC

Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C

Broader categories

VR headsets tested as a possible treatment for blindness